← Open Payments lookup

JULIE BIGHOUSE: Open Payments

NPI 1720075591 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$797 in 44 payments from 16 companies in 2025. Trend: 2023 $537 · 2024 $850 · 2025 $797

Food & beverage: $797
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation11$172
E.R. Squibb & Sons, L.L.C.6$99
Merck Sharp & Dohme LLC5$99
Amgen Inc.4$61
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)2$51
Esperion Therapeutics, Inc.3$50
SCPHARMACEUTICALS INC.3$44
PFIZER INC.2$38
Alnylam Pharmaceuticals Inc.1$33
AstraZeneca Pharmaceuticals LP1$31

Products named: LEQVIO, CAMZYOS, VERQUVO, REPATHA, LifeVest, NEXLETOL, FUROSCIX, ONPATTRO.

Industry payments across TX — which companies pay providers there.